ReviewAnnals of hematology2024
BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma.
Jiamin Fang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewAnnals of hematology2024
Jiamin Fang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.